Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
04.09. | Ametris starts obesity digital endpoint project with pharma | ||
04.09. | Dismay as Florida seeks to end vaccination protections | ||
04.09. | Medical groups, federal staffers call for RFK Jr to resign | ||
03.09. | Novartis pens $5.2bn cardiovascular partnership with Argo | ||
03.09. | Eisai moves swiftly to expand subcutaneous Leqembi label | ||
03.09. | Merck KGaA names new R&D chief for healthcare business | ||
03.09. | MSD, Ionis trumpet lipid-lowering drug data | ||
03.09. | A vaccine adcomm expert criticised RFK Jr - now he's out | ||
02.09. | 'Brainwave' test raises hopes of early dementia diagnosis | ||
02.09. | Ex-CDC chiefs sound alarm bells over HHS under Kennedy | ||
02.09. | OMass attracts $420m Roche wager on IBD programme | ||
02.09. | Uni wins big NIHR grant for healthtech 'horizon scanning' | ||
01.09. | ESC: MSD/Bayer's Verquvo disappoints in heart failure trial | ||
01.09. | IPO plan evaporates as private equity firm buys Stada | ||
01.09. | ESC: Real-world study gives Wegovy edge over Lilly rival | ||
01.09. | Sanofi breaks new ground for BTK drugs with ITP approval | ||
01.09. | ESC: 'Landmark' study backs AZ's baxdrostat for hypertension | ||
01.09. | Dose-at-home Leqembi for Alzheimer's cleared in US | ||
29.08. | Trump appoints HHS deputy O'Neill to lead CDC | ||
29.08. | UK adds chickenpox to childhood vaccination schedule | ||
28.08. | Outlook blindsided as FDA blocks wet AMD drug once again | ||
28.08. | Novo reels in Replicate for new cardiometabolic drugs | ||
28.08. | Scoop: Lumos Labs has FDA nod for ADHD DtX Prismira | ||
28.08. | Lilly pauses Mounjaro shipments to UK ahead of price hike | ||
28.08. | Stada revives talk of an IPO - if conditions improve |